Here, we make two contributions to knowledge concerning the private costs of complying with the current regulatory approval system for agrifood biotechnologies1. First, we characterize the structure of such compliance costs and identify key dimensions of their variability. Second, we provide estimates of representative compliance costs for selected maize biotechnologies. Our estimates are based on reviews and analyses of dossiers submitted to regulatory agencies, and firm-level data on associated expenses.